Skip to main content
. 2022 Jul 30;14(8):1592. doi: 10.3390/pharmaceutics14081592

Figure 8.

Figure 8

Swelling trend of formulations containing (a) AG alone (F1–F4), (b) Carbopol alone (F5–F8), and (c) AG-CP composite (F9–F12).